Interferons (IFN), cytokines and growth factors play important roles as a first defense against viral infections, in the treatment of different types of cancers and in the regulation of the immune and hematopoietic system. Their effects involve almost every system in the organism underscoring their broad effects and the importance of elucidating their signaling mechanisms. Cytokine, growth factors and IFNs have similar signaling mechanism that involve receptor binding and activation of tyrosine kinases and transcription factors of the Jak and Stat (Signal Transducers and Activators of Transcription) families, that results in the transcriptional activation of genes responsible for the different cytokine responses. However, little is known about the mechanisms by which cytokine receptors activate the Jak kinases and Stat factors. This application attempts to characterize the mechanisms used by cytokine receptors to activate the Jak kinases. We will test the hypothesis that similar domains present in the cytoplasmic region of cytokine receptors may be utilized for the interaction and activation of Jak kinases. However, this cytoplasmic domain may have different roles in the activation of Jak1 and Jak2 by distinct receptors. In the first Specific Aims of this proposal is focused on the characterization of the Jak1 binding domain present in different cytokine receptors that activate this kinase. We will also characterize the domains in the Jak kinases that are required for the interaction with different cytokine receptors. The second Specific Aim proposed to test different models for the interaction/ activation between cytokine receptors and Jak kinases, stressing the interaction/activation of cytokine receptors with Jak1 and Jak2. To achieve these goals we propose in vivo and in vitro studies such as the production of GST fusion protein encoding mutation of the appropriate binding sites, two hybrid system, production of recombinant proteins using in vitro translation systems, transient and stable expression of recombinant proteins in different mammalian cells. The results obtained with this proposal will be important not only to understand the signaling pathway of IFNalpha, but also signaling by different cytokine receptors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA055079-08
Application #
6375908
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Program Officer
Mccarthy, Susan A
Project Start
1994-06-21
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
8
Fiscal Year
2001
Total Cost
$209,448
Indirect Cost
Name
University of Illinois at Chicago
Department
Pharmacology
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Datta, Abhishek; Nag, Alo; Pan, Wei et al. (2004) Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J Biol Chem 279:36698-707
Sandoval, Raudel; Xue, Jiaping; Pilkinton, Mark et al. (2004) Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines. J Biol Chem 279:32275-80
Usacheva, Anna; Tian, Xinyong; Sandoval, Raudel et al. (2003) The WD motif-containing protein RACK-1 functions as a scaffold protein within the type I IFN receptor-signaling complex. J Immunol 171:2989-94
Prejean, C; Sarma, T; Kurnasov, O et al. (2001) Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J Immunol 167:4553-9
Russell-Harde, D; Wagner, T C; Rani, M R et al. (2000) Role of the intracellular domain of the human type I interferon receptor 2 chain (IFNAR2c) in interferon signaling. Expression of IFNAR2c truncation mutants in U5A cells. J Biol Chem 275:23981-5
Croze, E; Usacheva, A; Asarnow, D et al. (2000) Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type I IFN receptor. J Immunol 165:5127-32
Prejean, C; Colamonici, O R (2000) Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling. Semin Cancer Biol 10:83-92
Domanski, P; Nadeau, O W; Platanias, L C et al. (1998) Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta. J Biol Chem 273:3144-7
Domanski, P; Fish, E; Nadeau, O W et al. (1997) A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J Biol Chem 272:26388-93
Platanias, L C; Uddin, S; Domanski, P et al. (1996) Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. J Biol Chem 271:23630-3

Showing the most recent 10 out of 17 publications